Logo

FDA submission

Enzo Biochem Q1 2022 Revenues Down 8 Percent

The company said its life sciences revenues fell 9 percent from Q1 2021 because of ongoing COVID-19-related shutdowns in Europe, among other reasons.

Geneoscopy Closes $105M Series B Financing Round

The company said it will use the funds in part to support a study of ColonoSight, its multi-target stool RNA test for colorectal screening.

German MDx Firm Mainz Biomed Raises $10M in IPO, Begins Trading on Nasdaq

The company, which has been developing a colorectal cancer diagnostic called ColoAlert, priced its IPO last week, offering 2 million shares at $5 per share.

Tempus Submits PMA Application for Tumor Profiling Assay to FDA

The firm has submitted companion diagnostic and tumor profiling, and MSI status claims using DNA from FFPE tumor tissue and matched normal specimens.

Biocartis Files FDA Submission for Microsatellite Instability Test in Colorectal Cancer

The assay is intended to detect

Apr 2, 2021

Allarity Therapeutics Seeks FDA Premarket Approval for Prediction Tool as CDx for Dovitinib

Nov 24, 2020

Startup Angstrom Bio Plans Saliva-Based COVID-19 Nucleic Acid Test on Nanopore Sequencing Platform
Premium

Nov 11, 2020

Adaptive Biotechnologies Prepares to Launch T Cell-Based COVID-19 Test
Premium

Sep 28, 2020

Angle Files De Novo FDA Submission for CTC Collection Device in Breast Cancer

Sep 25, 2020

NIH Awardee MatMaCorp Developing SARS-CoV-2 Molecular Test for Rural Hospitals
Premium

Sep 23, 2020

Becton Dickinson Submits Premarket Approval Supplement to FDA for HPV Assay

Aug 7, 2020

Illumina Sees Expanding Sequencing Market in COVID-19 Response, Despite Short-Term Woes
Premium

Jul 20, 2020

Sepset Biosciences Leveraging COVID-19 Patient Samples in Study to Validate Sepsis Test
Premium

Jun 16, 2020

Immunexpress Nabs $599K BARDA Contract to Develop Sepsis Test for Coronavirus Patient Triage

Jun 8, 2020

QuantuMDx Receives CE-IVD Marking for SARS-CoV-2 Test

May 29, 2020

Fry Laboratories Plans COVID-19 NGS Diagnostic Kit Offering
Premium

May 13, 2020

Adaptive Eyes NGS-Based Test for T Cell Response in COVID-19
Premium

Apr 14, 2020

Merck Bid for Second Pan-Cancer Keytruda Indication Would Raise Tumor Mutation Burden to CDx Status
Premium

Apr 2, 2020

Siemens Healthineers Developing Molecular Kit for Coronavirus Detection

Mar 25, 2020

Sentinel Diagnostics Looks to Expand Global Influence With SARS-CoV-2 Test

Mar 11, 2020

Coronavirus Test From GenMark Diagnostics Submitted to FDA for Emergency Use Authorization

Feb 24, 2020

Luminex Submits Verigene II Respiratory Assay for FDA Clearance

Feb 20, 2020

FDA Releases List of Evidence-Based PGx Variants

Jan 21, 2020

Myriad Genetics Files for FDA Approval of BRACAnalysis CDx for Lynparza in Prostate Cancer

Jan 14, 2020

BioMérieux Submits 43-Target BCID2 Test to FDA

Breaking News
The Scan

Transplant Tests Edited Pig Kidneys

The Associated Press reports a University of Alabama-Birmingham team transplanted genetically modified pig kidneys into a brain-dead human patient.

UK Changes Some Gene-Edited Crop Rules

A new law may enable gene-edited crops to be sold in the UK within about five years, New Scientist says.

Pill Works Against Omicron in Lab

Pfizer's antiviral pill to treat SARS-CoV-2 appears to work against the Omicron variant, the Wall Street Journal reports.

Nature Papers Find Genetic Risk Factor for Smell, Taste Loss in COVID-19; Analyze TB Granulomas

In Nature this week: genome-wide association study find locus linked to the risk COVID-19 patients losing their sense of taste or smell, and more.